Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-20

Clinical Trial Update: ESKETamine for FIBromyalgia Treatment [NA]

View source ↗

Summary

A clinical trial evaluating esketamine for fibromyalgia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Esketamine (esketamine)

Snippet

Sponsor: Grand Hôpital de Charleroi | Conditions: Fibromyalgia | NA | Status: TERMINATED